Protarga begins Phase II

Protarga (Conshohocken, Penn.) began a 400-patient Phase II trial in the U.S. and U.K. of Taxoprexin DHA-paclitaxel to treat patients with breast, colorectal, kidney, lung, pancreas, prostate, skin an...